This study aimed to investigate the potential association between the polymorphism of the Interlukin-6 gene (G˃C) at position + 565 SNP. and type 1 diabetes (T1D) in Iraqi patients, the study included 39 blood samples which have withdrawn from diabetic patients (12 males and 27 females and an average age of 15.65 ± 1.79 years) who were diagnosed by a medical staff at Baquba General Hospital for the period from October 2015 to March 2016 together with 21 blood samples from apparently healthy people as a control group (7 males and females and an average age of 14.26 ±1.43 years). The polymerase chain reaction-specific sequence primer (PCR-SSP) assay has been used in this study. The results revealed that comparing IL6+590 genotypes and alleles between T1D patients and controls showed some significant variance. The results of the gel electrophoresis of the IL-6 G / C + 565 gene amplified by PCR-SSP showed that the two genes G and C were present and that there were three genotypes: GG, GC, CC among patients. The results showed that frequency of GG genotype (56.41 vs 28.57%; respectively) and G allele (74.36 vs 59.52%; RR =36.7%) was significantly increased in diabetic patients in comparison with the controls (P = 0.058 and 0.102, respectively) and the related RR rates were 39.0% and 36.7%, respectively, while the associated EF values were 3.24 and 1.97, respectively. In contrast, GC genotype (35.89 vs 61.90%; P =0.063; PF =0.34) and C allele (25.64 vs 40.48%; P =0.102; PF =0.51) frequencies were significantly decreased in patients. The findings of this study depict the predominant pathogenic role of IL-6+565 polymorphism showed associations (positive and negative) with
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G/C and IL6 +565 G/A) has two SNPs location which are the most frequently studied genetic variations of the gene, and previous studies demonstrated that the first SNP is effective in regulating IL-6 production, and IL-6 -174 G allele was associated with high levels of IL-6 which is produced primarily by mononuclear phagocytes, fibroblasts, and vascular endothelial cells, and some activated T cells can also secrete IL-6 (11). IL-6 is a multi-functional cytokine which plays a role in adaptive immune response, inflammation, hematopoiesis and endocrine system (2, 10) . Although IL-6 was originally considered to be a pro-inflammatory cytokine, several discoveries prompted a revision of its characteristics and indicated that it also has antiinflammatory properties. For instance, IL-6 inhibited neutrophil accumulation after lipopolysaccharide (LPS) injection and antagonized the actions of IL-1β and TNF-α via induction of the soluble IL-1Ra and the soluble TNF-α receptor (4). Furthermore, IL-6 was found to be required to control the pro-inflammatory cytokines levels, such as TNF-α, in vivo after endotoxic insults, both locally and systemically, and under certain conditions, it has antiinflammatory characteristics in macrophages (7) .Therefore this study aimed to investigate the potential association between the polymorphism of the Interlukin-6 gene (G˃C) at position + 
Detection of IL6 Polymorphism
From EDTA blood the Genomic DNA was extracted using Wizard Genomic DNA Purification Kit (Promega, USA). The polymorphism was detected at IL-6 position of the promoter region (IL6+565) by polymerase chain reaction-specific sequence primer (PCR-SSP) assay, followed by electrophoresis on 2% agarose-gel, by using CTS-PCRSSP Tray Kit (Heidelberg-Germany). The thermo cycling conditions were: initial denaturation at 94˚C for 2minutes, followed by denaturation at 94˚C for 15seconds, and then 10 cycles of annealing and extension at 65˚C for 60 seconds. This was followed by denaturation at 94˚C for 15 seconds, and then 20 cyclesof annealing 61˚C at 50 seconds and extension at 72˚Cfor 30 seconds Figure (1). 
Figure:1 Agarose gel electrophoresis patterens of IL-6+565 gene region

Statistical Analysis
Genotypes of IL6+565 SNP were presented as percentage frequencies, and significant differences between their distributions in IBD patients and controls were assessed by twotailed Fisher's exact probability (P). In addition, relative risk (RR),etiological fraction (EF) and preventive fraction (PF)were also estimated to define the association between a genotype with the disease. These estimations were calculated by using the WINPEPI computer programs for epidemiologists. The latest version of the WINPEPI package is available free online athttp://www.brixtonhealth.com.
Results and Discussion
The SNP of IL6+565 was presented with three genotypes (GG, GC and CC) that corresponded to two alleles (G and C). These genotypes were in a good agreement with Hardy-Weinberg equilibrium (HWE) in both groups of patients, and controls. In addition, comparing T1D patients with controls also revealed significant differences in the distribution of IL6+565 genotypes and alleles. Among patients, frequencies of GG genotype (56.41 VS. 28.57%; RR =39.0%) and G allele (74.36vs. 59.52%; RR =36.7%) were significantly increased in patients compared to controls (P = 0.058 and0.102, respectively). In contrast, GC genotype (35.89 vs.
61.90%; P =0.063; PF =0.34) and C allele (25.64vs. 40.48%; P =0.102; PF =0.51) frequencies were significantly decreased in patients compared to controls; while no significant difference was observed in the frequencies of CC genotype (7.69 vs. 9.52 %; P =1.000; PF =0.79) between patients and controls in the distribution of IL6+565 genotypes and alleles (Tables 1   and 2 ). The present results strongly suggest that IL6+565 polymorphism is involved in groups of T1D in terms of susceptibility (positive association) and protection (negative association); especially in patients, in whom the RR of GG genotype reached 39.0% , and the protective effect of GC genotype was 0.34 . Therefore, IL6 allelic changes at position +565 might be associated with increased and decreased risk of T1DM in Iraqi population, and this may also contribute to a better clinic diagnosis. Other studies investigated other polymorphisms in intron and promoter regions of IL6 gene like Kyi et al.(14) and Elmarakby and Sullivan (13) and the results were almost conflicting due to ethnic variations, but they agreed that IL-6 is an important cytokine involved in immunity and its polymorphisms play a critical role in T1DM development Such conclusion has also been favored by Javor and co-workers (9) who investigated the prevalence of IL6+565 polymorphism in 151 Slovak T1DM patients and 140 controls, and reported similar findings. In addition Kristiansen and Poulsen (11) have investigated a further SNP in this region (IL6-174) in Danish patients and reported that such SNP was positively associated with the disease. In conclusion, SNPs of IL6 might have a role in etiopathogenesis of T1DM and suggesting that dysregulation of the IL-6 pathway may be a common feature of autoimmunity disease (12 
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